All Stories

  1. Correction to Lancet Neurol 2026; 25: 451–68
  2. Isolation of a multidrug-resistant Candida auris Clade V from an asymptomatic acute myeloid leukemia patient in the intensive care unit
  3. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. Efficacy Evaluation of Luliconazole‐Loaded Nanostructured Lipid Carriers in Treatment‐Resistant Dermatophytosis: A Randomized Clinical Trial
  5. Correction to Lancet Infect Dis 2026; published online June 2. https://doi.org/10.1016/S1473-3099(26)00194-5
  6. Correction to Lancet Infect Dis 2026; 26: 343–61
  7. Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review
  8. Correction to Lancet Infect Dis 2026; 26: 343–61
  9. A deep dive into the diversity of the Aspergillus community in the lakes of northern Iran
  10. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  11. Assessment of skin yeast colonization and its predisposing factors among neonates admitted to the neonatal intensive care unit
  12. Reviewer Thank You List 2025
  13. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis
  14. Reviewer Thank You List 2025
  15. Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice
  16. Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity
  17. Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)
  18. Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model
  19. A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature
  20. Deciphering Fluconazole Resistance in Candida auris clade V: The Role of Efflux Pump Gene Expression and Ergosterol Pathway Mutations
  21. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  22. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  23. Acknowledging our reviewers
  24. Acknowledgement to Reviewers
  25. Genetic diversity and antibiotic resistance patterns of Escherichia coli isolates causing septicemia: A phylogenetic typing and PFGE analysis
  26. Reviewer acknowledgment 2024
  27. Prevalence of Fungal Infections in Pemphigus Patients: A Systematic Review and Meta‐Analysis
  28. Reviewer Acknowledgement 2024
  29. Reviewer Thank You List 2024
  30. An Unusual High Prevalence of Cryptococcus (Naganishia) diffluens Colonization in Neonates Hospitalized in a Referral Neonatal Intensive Care Unit
  31. Multi‐state evaluation of Candida infections in burn patients
  32. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  33. High Prevalence of Terbinafine Resistance Among Trichophyton mentagrophytes/T. interdigitale Species Complex, a Cross-Sectional Study from 2021 to 2022 in Northern Parts of Iran
  34. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide Study
  35. Editorial Board
  36. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  37. Central nervous system Aspergillus quadrilineatus infection in a COVID‐19 patient, a case report and literature review
  38. Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment
  39. Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran
  40. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  41. Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains
  42. Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis
  43. Acknowledgment to the Reviewers of Journal of Fungi in 2022
  44. Acknowledgment to the Reviewers of Diagnostics in 2022
  45. Acknowledgment to the Reviewers of Antibiotics in 2022
  46. Acknowledgment to the Reviewers of Life in 2022
  47. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice
  48. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs
  49. 2022 OFID Reviewer Recognition List
  50. A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles
  51. First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile
  52. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis
  53. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran
  54. P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis
  55. P285 Predominance of Trichophyton tonsurans causing tinea capitis: a 12-years retrospective study in north of Iran
  56. Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
  57. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling
  58. Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran
  59. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  60. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology
  61. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study
  62. 2021 OFID Reviewer Recognition List
  63. Antifungal Properties of Zataria multiflora on Candida species: A Systematic Review
  64. Acknowledgment of Reviewers 2021
  65. Acknowledgment of Reviewers 2021
  66. In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis
  67. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐center experience in Iran
  68. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice
  69. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis
  70. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran
  71. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects
  72. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  73. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
  74. Candida africana vulvovaginitis: Prevalence and geographical distribution
  75. Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis
  76. Cryptococcus and cryptococcosis in Iran during 1969–2019: A systematic review and meta-analysis
  77. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  78. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis
  79. Cover Image
  80. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  81. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends
  82. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  83. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism
  84. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples
  85. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  86. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review
  87. <i>Toxoplasma gondii</i> Genotypes and Feline: Geographical Distribution Trends